Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study

Bibliographic Details
Main Authors: Lawson, C, Griffiths, B, Ponchel, F, Hale, G, Waldmann, H, Isaacs, J
Format: Conference item
Published: 2005
_version_ 1826257582414626816
author Lawson, C
Griffiths, B
Ponchel, F
Hale, G
Waldmann, H
Isaacs, J
author_facet Lawson, C
Griffiths, B
Ponchel, F
Hale, G
Waldmann, H
Isaacs, J
author_sort Lawson, C
collection OXFORD
description
first_indexed 2024-03-06T18:20:29Z
format Conference item
id oxford-uuid:061a7577-998b-4687-8e0a-2ce7bc269745
institution University of Oxford
last_indexed 2024-03-06T18:20:29Z
publishDate 2005
record_format dspace
spelling oxford-uuid:061a7577-998b-4687-8e0a-2ce7bc2697452022-03-26T09:00:54ZAglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety studyConference itemhttp://purl.org/coar/resource_type/c_5794uuid:061a7577-998b-4687-8e0a-2ce7bc269745Symplectic Elements at Oxford2005Lawson, CGriffiths, BPonchel, FHale, GWaldmann, HIsaacs, J
spellingShingle Lawson, C
Griffiths, B
Ponchel, F
Hale, G
Waldmann, H
Isaacs, J
Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
title Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
title_full Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
title_fullStr Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
title_full_unstemmed Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
title_short Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
title_sort aglycosyl anti cd3 monoclonal antibody therapy in rheumatoid arthritis results of a pilot safety study
work_keys_str_mv AT lawsonc aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy
AT griffithsb aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy
AT ponchelf aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy
AT haleg aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy
AT waldmannh aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy
AT isaacsj aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy